4.7 Article

The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia

期刊

JOURNAL OF CLINICAL MEDICINE
卷 11, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/jcm11061533

关键词

fibromyalgia; small fiber neuropathy; screening; pain

资金

  1. Programma VALERE, University of Campania Luigi Vanvitelli

向作者/读者索取更多资源

This study assessed the presence of small and large fiber impairment in fibromyalgic patients and found a high prevalence of neuropathic pain in these individuals.
Fibromyalgia syndrome (sFM) is one of the most common causes of chronic pain. This study aimed to assess the presence of small and large fiber impairment in fibromyalgic patients by applying validated scores used in the screening for diabetic neuropathy. The endpoints for the study were the assessment of neuropathy prevalence in sFM patients using the NerveCheck Master (NCM), the Michigan Neuropathy Screening Instrument (MNSI), the Diabetic Neuropathy Symptom (DNS) and the Douleur Neuropathique 4 Questions (DN4). The sample was composed of 46 subjects: subjects with sFM (n = 23) and healthy controls (HC) (n = 23). The positivity rates in each group for DN4 were significantly different (p < 0.001), with a prevalence in symptomatic subjects of 56.3% (n = 9) among sFM individuals. A similar difference was also observed with the DNS total score (p < 0.001). NCM and MNSI did not disclose significant differences between the two groups. This finding seems to confirm the data regarding the prevalence of a neuropathic pain in sFM patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据